Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders? A. A. M. WildeP. Langendijk editorial Pages: 127 - 128
Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? C. J. W. BorleffsA. A. M. WildeA. Mosterd original article Pages: 129 - 132
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study C. A. GelukR. A. TioF. Zijlstra original article Pages: 133 - 141
Exercise prescription for patients with a Fontan circulation: current evidence and future directions T. TakkenH. J. HulzebosJ. L. M. Strengers review article Pages: 142 - 147
Stent thrombosis associated with first-generation drug-eluting stents: issues with antiplatelet therapy P. A. GurbelD. E. Kandzari special article Pages: 148 - 150
Electrical storms in Brugada syndrome successfully treated with isoproterenol infusion and quinidine orally J. K. JongmanN. Jepkes-BruinA. Elvan case report Pages: 151 - 154
Crossing coronary arteries E. S. ZegersM. W. A. VerkroostF. W. A. Verheugt imaging in cardiology Pages: 155 - 156
Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy T. GermansA. A. M. WildeA. C. van Rossum editorial Pages: 161 - 163